CBM - Cambrex Corporation
Previous close
59.99
0 0%
Share volume: 0
Last Updated: Tue 03 Dec 2019 06:00:00 AM CET
Chemicals: Specialty:
0%
PREVIOUS CLOSE
CHG
CHG%
$59.99
0.00
0.00%
Fundamental analysis
370%
Profitability
400%
Dept financing
200%
Liquidity
300%
Performance
400%
Performance
5 Days
0 0%
1 Month
0 0%
3 Months
0 0%
6 Months
0 0%
1 Year
0 0%
2 Year
0 0%
Key data
Stock price
$59.99
DAY RANGE
$59.99 - $59.99
52 WEEK RANGE
$33.80 - $60.29
52 WEEK CHANGE
$28.51
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Steven M. Klosk
Region: US
Website: http://www.cambrex.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Chemicals: Specialty
Sector: Process Industries
Region: US
Website: http://www.cambrex.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Chemicals: Specialty
Sector: Process Industries
Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in December 1981 and is headquartered in East Rutherford, NJ.
Recent news